Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Microkeratome users benefit from control, safety, performance
Philadelphia-The K-TOME microkeratome offers a range of desirable characteristics that make it an excellent choice for refractive surgeons, but unsurpassed control tops that feature list, said J. Charles Casebeer, MD. He spoke about the instrument, introduced in 1997 by Innovative Optics. Paradigm Medical Industries acquired that company last January and launched the K-TOME at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) here.
Related Videos
Related Content
